Total raised
—
Stage
Seed
Founded
2016
Headcount
6
HQ
Haifa
Sector
Health Tech & Life Sciences
About
CanCuRX is a preclinical-stage biopharmaceutical company aiming to improve survival for patients with pancreatic cancer through the development of a novel treatment based on the properties of a mushroom-derived compound that arrests pancreatic cell growth. CanCuRX is working with the Carmel Innovations Fund of the University of Haifa. CanCuRX has patents registered for the mushroom strain, the extract prepared from it, and the treatment process.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is CanCuRX's primary focus?
- CanCuRX is a preclinical-stage biopharmaceutical company focused on developing a novel treatment for pancreatic cancer.
- What is the basis of CanCuRX's treatment for pancreatic cancer?
- CanCuRX's treatment is based on a mushroom-derived compound that is designed to arrest pancreatic cell growth.
- When was CanCuRX founded?
- CanCuRX was founded in February 2016.
- Where is CanCuRX headquartered?
- CanCuRX is headquartered in Haifa, Israel, specifically at the Eshkol Tower, University of Haifa.
- Which organization is CanCuRX working with?
- CanCuRX is working with the Carmel Innovations Fund of the University of Haifa.
- Does CanCuRX hold any patents?
- Yes, CanCuRX has patents registered for the mushroom strain, the extract prepared from it, and the treatment process.
- What is CanCuRX's current funding stage?
- CanCuRX is currently in the Seed funding stage.
- How many employees does CanCuRX have?
- CanCuRX has between 1 and 10 employees, with an exact count of 6.
- Who are the founders of CanCuRX?
- The founders of CanCuRX are Prof. Fuad Fares and Dr. Lital Sharvit.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue Engineering
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
cancer-therapycancerbiopharmaceuticalpharmaceuticalstreatmentspharma-companies